ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Recursos principais

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Viking Therapeutics Inc

Viking Therapeutics Inc (VKTX)

72,88
0,34
(0,47%)
Fechado 02 Novembro 5:00PM
73,48
0,60
(0,82%)
Após o horário de negociação: 8:57PM

Calls

StrikeOfertaVendaÚltimo PreçoPonto MédioVariação do DiaVariação do Dia %VolumeINT ABERTOÚltimo Negócio
63,0010,3013,4011,8911,850,000,00 %011-
64,009,1012,8013,0010,950,383,01 %23001/11/2024
65,0010,2011,0010,9210,60-0,38-3,36 %5916901/11/2024
66,007,8010,5017,209,150,000,00 %0539-
67,007,0011,4010,009,20-0,44-4,21 %1552301/11/2024
68,008,409,109,178,75-0,83-8,30 %2810101/11/2024
69,007,9010,508,479,20-0,53-5,89 %283601/11/2024
70,007,408,007,707,70-1,00-11,49 %42358901/11/2024
71,006,807,507,557,15-0,65-7,93 %247101/11/2024
72,006,407,107,116,75-0,10-1,39 %3315201/11/2024
73,006,106,606,306,35-0,60-8,70 %24516301/11/2024
74,005,706,106,005,90-0,46-7,12 %12033501/11/2024
75,005,305,705,575,50-0,42-7,01 %1.13694401/11/2024
76,004,905,405,105,15-0,96-15,84 %7041001/11/2024
77,004,606,904,905,75-0,60-10,91 %14412201/11/2024
78,004,204,704,504,45-0,40-8,16 %5119601/11/2024
79,004,004,304,254,15-0,69-13,97 %774701/11/2024
80,003,703,903,703,80-0,50-11,90 %5.4943.33301/11/2024
81,003,503,703,573,60-1,23-25,62 %566401/11/2024
82,003,003,403,503,20-0,55-13,58 %1225301/11/2024

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Puts

StrikeOfertaVendaÚltimo PreçoPonto MédioVariação do DiaVariação do Dia %VolumeINT ABERTOÚltimo Negócio
63,001,452,752,052,10-0,65-24,07 %957701/11/2024
64,002,152,902,502,525-1,00-28,57 %10360201/11/2024
65,002,502,952,602,725-0,70-21,21 %4801.03801/11/2024
66,003,003,303,003,15-0,59-16,43 %1688101/11/2024
67,003,003,703,543,35-0,47-11,72 %2513501/11/2024
68,002,554,103,853,325-0,61-13,68 %7611001/11/2024
69,003,505,204,104,35-1,10-21,15 %323701/11/2024
70,004,705,004,724,85-0,98-17,19 %1.7511.10301/11/2024
71,003,506,005,604,75-0,40-6,67 %163801/11/2024
72,005,606,205,705,90-1,20-17,39 %315401/11/2024
73,006,206,906,606,55-0,56-7,82 %4110201/11/2024
74,005,307,407,106,35-0,25-3,40 %398401/11/2024
75,007,307,907,507,60-0,20-2,60 %748101/11/2024
76,005,509,708,507,60-0,60-6,59 %17001/11/2024
77,006,809,3010,088,050,000,00 %0562-
78,007,309,809,678,550,171,79 %51601/11/2024
79,008,2010,409,459,300,000,00 %2001/11/2024
80,009,6013,4011,0211,50-0,58-5,00 %1253101/11/2024
81,0010,1013,400,0011,750,000,00 %00-
82,0010,1013,200,0011,650,000,00 %00-

Rankings

Ver todos
  • Volume
  • % Altas
  • % Quedas
CódigoPreçoVol.
VSTEVast Renewable Ltd
US$ 4,98
(149,00%)
68,54M
INVZWInnoviz Technologies Ltd
US$ 0,096
(96,71%)
22,71k
CDXCChromaDex Corporation
US$ 5,87
(68,19%)
37,88M
ATHAAthira Pharma Inc
US$ 0,606
(41,56%)
239,63M
TILEInterface Inc
US$ 23,24
(33,03%)
2,16M
EPIXESSA Pharma Inc
US$ 1,45
(-72,12%)
33,85M
ELABElevai Labs Inc
US$ 0,0288
(-51,19%)
201,61M
OSTOstin Technology Group Company Ltd
US$ 0,275
(-45,00%)
2,27M
LXRXLexicon Pharmaceuticals Inc
US$ 1,23
(-36,92%)
19,96M
VCIGVCI Global Ltd
US$ 0,0583
(-27,58%)
26,13M
ATHAAthira Pharma Inc
US$ 0,606
(41,56%)
236,07M
SQQQProShares UltraPro Short QQQ
US$ 7,44
(-2,11%)
214,96M
NVDANVIDIA Corporation
US$ 135,40
(1,99%)
206,38M
ELABElevai Labs Inc
US$ 0,0288
(-51,19%)
201,61M
INTCIntel Corporation
US$ 23,20
(7,81%)
171,4M
Monksdream Monksdream 4 minutos atrás
CETX new 52+week low
https://investorshub.advfn.com/uimage/uploads/2024/11/2/jtzhzIMG_2953.gif
CETX
ChannelTrader ChannelTrader 4 minutos atrás
Awesome
Doc logic Doc logic 5 minutos atrás
FeMike,

I guess I am just asking if you think that 600 patients paying $150,000 for treatment is doable within the first year after approval. That was my estimate of year one revenue post approval that Investor082 thinks is too rich. I think revenue from small clinical trials will s
NWBO
Viewmont Viewmont 5 minutos atrás
Survivalist2008
@filmy98706
·
2h
Greetings $ADHC friends, I spent the morning doing some research on ADHC and liked what I saw. Yes that was me buying up those 36's and 37's and 38's 😊 Looking forward to the next run hopefully above penny land.
ADHC
ksquared ksquared 5 minutos atrás
Nice win for the Buckeyes in UNhappy Valley.
Hope you enjoyed the game.
mineanddine mineanddine 6 minutos atrás
Dreamers believe anything.  Miro makes his living by shafting the gullible.  
HIRU
FeMike FeMike 6 minutos atrás
“Thermo's pumping”? Sure, whatever makes you happy :)
Uh huh…so if not pumping, what would you call it when someone who claims to be a financier of multiple installments of millions of dollars for a public startup and has much more detailed conversations with management than retail to the poi
NWBO
Whalatane Whalatane 7 minutos atrás
Zip. AMRN does not need a higher volume of API purchases . They still have $74 m in long term inventory ...in addition to their existing inventory .
In fact a higher volume of API is probably the last thing they need ...since they had to buy their way out of their previous supply agreement
AMRN API
Myth Myth 8 minutos atrás
I'll pass on that Cap, but thanks for the heads up.....

GL !
zab zab 8 minutos atrás
West Virginia ranks # 48 on Healthcare, it's a good thing for all of those residents, more time to stay home.
vein vein 9 minutos atrás
One million is chump change . Hardly a vote of confidence 
LWLG
gitreal gitreal 9 minutos atrás
Have you seen this government official poking around the Shambhala claims?? Department of Land Transfer!! Just kidding, it's just Steve Cyros pretending to be a government official! Look at that crisp, clean uniform. The radio clipped to his shoulder, ready to call in his deputies! His brand n
BYRG
BDEZ BDEZ 10 minutos atrás
Somali leaders in Minny just endorsed 45

https://x.com/ConservBrief/status/1852787168248230399
raiderz raiderz 11 minutos atrás
I’ve been wondering whether the Truist filing could be the result of a single individual depositing a big chunk of shares, and Truist is acting as the holder in trust.

Is that possible with a 13G?

If yes, could the depositor be Miro and his wife? 🤣😭 or m
HIRU
janice shell janice shell 12 minutos atrás
Also nobody has answered my basic question yet, how long after not filing their 10K does smci have before they are delisted?

That is up to the Nasdaq. They tend to take their time.
Candy Man6 Candy Man6 13 minutos atrás
I was very happy to find that the Irish license has been approved for a while and now, as of October 8th, there is an Irish Swifty Website that is operational and taking bets.
I can't find any other Swifty website that is operational and taking bets, as a couple of them are touted as coming s
SGN
learningcurve2020 learningcurve2020 13 minutos atrás
Come on Ex!  Look at the history and the governance.  We knew none of it was going to happen but Thermo's out their selling the company while making no demands on management to benefit retail.  
NWBO
BDEZ BDEZ 15 minutos atrás
This lady that Harris got knocking doors

https://x.com/hodgetwins/status/1852729095177503052
poguemahone poguemahone 16 minutos atrás
What happened to $1249?
AVXL
pennyonfire pennyonfire 16 minutos atrás
$ZHUD .023 5year chart:

https://www.barchart.com/stocks/quotes/ZHUD/technical-chart?plot=BAR&volume=0&data=MO&density=L&pricesOn=1&asPctChange=0&logscale=0&indicators=BBANDS(20,2);PTP(50);SMA(20);SMA(200);SMA(50);ACCUM;RSI(14,100);CHKMF(20);MFI(14,100)&sym=ZHUD&grid=1&height=210&study
MFI ZHUD
frrol frrol 16 minutos atrás
If improved blood based tests continue to show strong correlation with PET and CSF diagnostics, they will indeed likely become accepted for AD diagnosis and AD clinical trials.
AVXL
learningcurve2020 learningcurve2020 17 minutos atrás
BS. I've already pointed out Geron and other companies who didn't need to go under the forever cone of silence while waiting on regulators.  She could've easily changed the terms of the loan start due date with a little sweetener (and we know she just loves those sweeteners!). 
NWBO
fuagf fuagf 18 minutos atrás
No statements for violence as that acceptable here.
Hosai Hosai 18 minutos atrás
Technically if you believe that EMA approval would justify around an $80 dollar share price as some have said here then at 17% chance you would believe sp should currently be around $13.6 a share...that would be ignoring 3-71 too.
AVXL

Seu Histórico Recente

Delayed Upgrade Clock